Skip to content
Screener

Total Assets at other companies

Arvinas logo
ArvinasARVN
$647.5M-35.3%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$1.65B+45.5%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$691.16M+92.2%
Septerna, Inc. logo
Septerna, Inc.SEPN
$569.69M+31.3%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$443.28M+8.9%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$1.29B+81.1%

Other financials

Income statement

See full
Revenue$9.0M-79.5%
Operating income-$94.2M-95.0%
Net income-$89.5M-106%
EPS (diluted)-$0.81-55.8%

Balance sheet

See full
Cash & equivalents$68.7M-19.4%
Total debt$58.1M+12.0%
Total equity$402.6M-10.0%

Cash flow

See full
Operating cash flow-$96.6M-52.9%
CapEx$1.9M-27.6%
Free cash flow-$98.5M-49.6%

Valuation

See full
Market cap$2.62B+227%
Enterprise value$2.61B+240%
P/S71.2×+62.1×

Profitability

See full
Operating margin-982.4%-1,538pp
Net margin-928.4%-1,403pp
FCF margin-378.7%+24.1pp

Returns & leverage

See full
Return on equity-80.3%+113pp
Debt / equity0.1×0.0×
Current ratio6.3×-0.5×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.

Filed
Jul 9, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001549595-26-000040
Line itemMay 31,2026November 30,2025
Property and equipment, net20,00722,490
Restricted cash968968
Other assets7,9777,341
Total assets$535,540$688,135
Liabilities and stockholdersʼ equity
Current liabilities:
Accounts payable$12,208$11,215
Accrued expenses and other current liabilities43,26754,852

Item 1. Financial Statements (Unaudited)

FAQ

What is Nurix Therapeutics, Inc.'s total assets?
Nurix Therapeutics, Inc. (NRIX) reported total assets of $535.54M in Q1 2026.
How has Nurix Therapeutics, Inc.'s total assets changed year-over-year?
Nurix Therapeutics, Inc.'s total assets decreased by 9.5% year-over-year, from $591.56M to $535.54M.
What is the long-term trend for Nurix Therapeutics, Inc.'s total assets?
Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s total assets has grown at a 11.7% compound annual growth rate (CAGR), from $396.34M to $688.14M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Ask your AI about Nurix Therapeutics, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude